150 related articles for article (PubMed ID: 25723370)
1. Key changes to cancer care in the UK.
Br J Nurs; 2015 Feb 26-Mar 11; 24(4):S3. PubMed ID: 25723370
[No Abstract] [Full Text] [Related]
2. UK Cancer Drugs Fund to reassess 42 agents.
Cagney H
Lancet Oncol; 2015 Jan; 16(1):e8. PubMed ID: 25638560
[No Abstract] [Full Text] [Related]
3. A question of health. The lottery of cancer care.
Health Serv J; 1997 Dec; 107(5584):suppl 1-4 following 24. PubMed ID: 10184833
[No Abstract] [Full Text] [Related]
4. British clinic is allowed to deny medicine; decision on cost has broad impact.
Lyall S
N Y Times Web; 2006 Feb; ():A10. PubMed ID: 16514743
[No Abstract] [Full Text] [Related]
5. Cancer drugs fund receives boost but will no longer fund "overpriced" drugs.
Hawkes N
BMJ; 2014 Sep; 349():g5382. PubMed ID: 25180006
[No Abstract] [Full Text] [Related]
6. Change ahead for cancer drug funding.
Lancet Haematol; 2015 Feb; 2(2):e47. PubMed ID: 26687606
[No Abstract] [Full Text] [Related]
7. Bad month for cancer care in the UK.
Lancet Oncol; 2010 Aug; 11(8):701. PubMed ID: 20688267
[No Abstract] [Full Text] [Related]
8. Court backs Briton's right to a costly drug.
Lyall S
N Y Times Web; 2006 Apr; ():A3. PubMed ID: 16649282
[No Abstract] [Full Text] [Related]
9. Finance: A small change to how we pay.
Girach M; Irwin R
Health Serv J; 2012 Jul; 122(6313):27. PubMed ID: 23074781
[No Abstract] [Full Text] [Related]
10. Cancer charity demands extension of drug fund despite criticisms it is unfair.
Limb M
BMJ; 2014 Oct; 349():g6507. PubMed ID: 25354675
[No Abstract] [Full Text] [Related]
11. Limits to Personalized Cancer Medicine.
Tannock IF; Hickman JA
N Engl J Med; 2016 Sep; 375(13):1289-94. PubMed ID: 27682039
[No Abstract] [Full Text] [Related]
12. Calling time on the Cancer Drugs Fund? Funding the NHS in the age of austerity.
Emmerich N
Br J Hosp Med (Lond); 2015 Apr; 76(4):186-7. PubMed ID: 25853345
[No Abstract] [Full Text] [Related]
13. Careful use of science to advance the debate on the UK Cancer Drugs Fund.
Lakdawalla DN; Jena AB; Doctor JN
JAMA; 2014 Jan; 311(1):25-6. PubMed ID: 24381964
[No Abstract] [Full Text] [Related]
14. Adjuvant trastuzumab for breast cancer: the other side of the coin.
Gopalakrishnan S; Linnane J
BMJ; 2005 Nov; 331(7526):1202-3. PubMed ID: 16293846
[No Abstract] [Full Text] [Related]
15. How can the UK National Health Service be broke?
Stephenson T
Arch Dis Child; 2007 Mar; 92(3):189-90. PubMed ID: 17337674
[TBL] [Abstract][Full Text] [Related]
16. Just a private matter.
Singleton C; Lehane M; Jeffs L; Justice S
Nurs Stand; 2008 Jul 2-8; 22(43):28-9. PubMed ID: 18655504
[No Abstract] [Full Text] [Related]
17. The New and Non-Transparent Cancer Drugs Fund.
Wood EM; Hughes DA
Pharmacoeconomics; 2020 Jan; 38(1):1-4. PubMed ID: 31828737
[No Abstract] [Full Text] [Related]
18. No evidence that £1bn Cancer Drugs Fund has helped patients, says watchdog.
Kmietowicz Z
BMJ; 2015 Sep; 351():h4988. PubMed ID: 26384368
[No Abstract] [Full Text] [Related]
19. More money for health care in the UK...more health?
Appleby J
J Health Serv Res Policy; 2003 Jan; 8(1):1-2. PubMed ID: 12683426
[No Abstract] [Full Text] [Related]
20. UK NHS: less money (but more bangs per buck)?
Appleby J
BMJ; 2015 Mar; 350():h1037. PubMed ID: 25757982
[No Abstract] [Full Text] [Related]
[Next] [New Search]
